Description
Flavamed (Ambroxol Hydrochloride) Tablets Against Cough 30 mg. №50
Ingredients:
Each tablet contains 30 mg of ambroxol hydrochloride as the active ingredient.
Mechanism of Action:
Ambroxol hydrochloride, the active ingredient in Flavamed tablets, is a mucolytic agent that facilitates the breakdown of mucus in the respiratory tract. This mechanism helps in improving mucus clearance and promoting easier expectoration of mucus.
Pharmacological Properties:
Flavamed tablets containing ambroxol hydrochloride exhibit mucolytic, expectorant, and secretolytic properties. These properties aid in reducing the viscosity of mucus, promoting its clearance, and facilitating easier removal from the respiratory system.
Indications for Use:
Flavamed tablets are indicated for the treatment of acute and chronic respiratory diseases characterized by excessive mucus production and impaired mucus clearance. These conditions may include bronchitis, chronic obstructive pulmonary disease (COPD), and asthma with associated mucus secretion issues.
Contraindications:
Flavamed tablets should not be administered to individuals with a known hypersensitivity to ambroxol hydrochloride or any other components present in the tablet formulation. Caution is advised in patients with a history of allergic reactions to similar compounds.
Side Effects:
Common side effects associated with the use of Flavamed tablets may include gastrointestinal disturbances such as nausea, vomiting, or diarrhea. Allergic reactions like skin rash or itching may also occur. While serious adverse effects are rare, immediate medical attention is necessary if severe reactions manifest.
Usage Instructions:
The recommended dosage for adults and children above 12 years of age is one tablet (30 mg) taken orally three times a day. The tablets should be swallowed whole with an adequate amount of water, and crushing or chewing them should be avoided to ensure optimal efficacy.
Benefits Compared to Analogues:
Flavamed tablets containing ambroxol hydrochloride offer a favorable benefit-risk profile compared to other mucolytic agents. The targeted action of ambroxol in reducing mucus viscosity and enhancing expectoration contributes to improved symptom relief and respiratory function in patients with respiratory conditions.
Suitable Patient Groups:
Flavamed tablets are suitable for use in various patient populations, including children above 12 years, adults, and elderly individuals, under appropriate medical supervision. Dosing adjustments may be necessary in patients with renal or hepatic impairment, warranting close monitoring during treatment.
Storage Conditions and Shelf Life:
Flavamed tablets should be stored in a cool, dry place away from direct sunlight and moisture. The shelf life of the product is typically indicated on the packaging and should be strictly adhered to for ensuring medication potency and safety.
Packaging Description:
Each package of Flavamed tablets contains 50 tablets, with each tablet individually sealed for protection. The packaging material is designed to maintain the stability and integrity of the tablets throughout their shelf life.
Clinical Evidence and Proven Effectiveness:
Ambroxol, the active ingredient in Flavamed tablets, has been extensively studied for its efficacy in respiratory conditions. Clinical studies have demonstrated that ambroxol can effectively enhance mucus clearance, reduce cough frequency, and improve respiratory symptoms in patients with acute and chronic respiratory diseases.
